Study of Specimens From Young Patients With Neuroblastoma

Completed

Conditions studied: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma

In brief

This research trial studies specimens from young patients with neuroblastoma. Studying the genes expressed in specimens from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

Key facts

Study ID

NCT00958659

Run by

Children's Oncology Group

People needed

350

Starts

2008-12-01

Expected to finish

2016-05-01

Last updated by the study team

2016-05-18

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of primary Neuroblastoma
• Untreated disease
• RNA samples from primary untreated NB-tumors available in Children's Oncology Group (COG) repository
• At least 60% tumor cells
• At least 2 years of follow-up from the date of diagnosis
• Full clinical and biological annotation

Where it is running

• Children's Oncology Group — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.